MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517034654 A) filed by PK Med, Paris, on April 9, for 'dosage form for intra articular injection comprising colchicine and an anesthesic agent in the treatment of crystal and non crystal associated acute inflammatory arthritis.'
Inventor(s) include Marzouki Farah; Sanson Charles; Pouletty Philippe; and Pouliquen Gauthier.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a pharmaceutical composition suitable for an intra articular injection comprising an anesthetic agent and an immediate or controlled release dosage form comprising colchicine. It further relates to a pharmaceutical composition under the form of a powder comprising an anesthetic agent and an immediate or controlled release dosage form comprising colchicine wherein said controlled release dosage form comprising colchicine are under the form of microparticles. It further relates to a pharmaceutical composition under the form of a powder comprising an anesthetic agent and an immediate or controlled release dosage form comprising colchicine wherein said controlled release dosage form comprising colchicine are under the form of microparticles to a kit and to the use of said pharmaceutical compositions or kit in the treatment of crystal associated and non crystal associated acute inflammatory arthritis in particular a crystal associated arthropathy or flares or acute forms of tendinitis and capsulitis by intra articular injection into a joint of said pharmaceutical composition and in providing pain relief immediately and all over the treatment."
The patent application was internationally filed on Oct. 24, 2023, under International application No.PCT/EP2023/079675.
Disclaimer: Curated by HT Syndication.
